Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5450]
News [12658]
Articles [175]
Editorials [5]
Conferences [249]
elearning [17]
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
Sotorasib for advanced non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
Sotorasib for advanced non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020
Development of novel inhibitors of KRASG12C
Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
Development of novel inhibitors of KRASG12C ( Dr Kevan Shokat - University of California San Francisco, San Francisco, USA )
4 Nov 2020
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1...
Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020
Managing multiple myeloma during the COVID-19 pandemic in Brazil
Dr Vania Hungria - Santa Casa de São Paulo, São Paulo, Brazil
Managing multiple myeloma during the COVID-19 pandemic in Brazil ( Dr Vania Hungria - Santa Casa de São Paulo, São Paulo, Brazil )
3 Nov 2020
Updates in surgical oncology from SIOG 2020
Dr Isacco Montroni - Ospedale per gli Infermi, Faenza, Italy
Updates in surgical oncology from SIOG 2020 ( Dr Isacco Montroni - Ospedale per gli Infermi, Faenza, Italy )
2 Nov 2020
Critical issues in drug and biomarker development
Prof Tracy Lively - National Cancer Institute, USA
Critical issues in drug and biomarker development ( Prof Tracy Lively - National Cancer Institute, USA )
2 Nov 2020
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
2 Nov 2020
Extreme hypofractionation with stereotactic body radiation therapy for elderly...
Dr Monica A Pernia - George Washington University, Washington DC, USA
Extreme hypofractionation with stereotactic body radiation therapy for elderly patients ( Dr Monica A Pernia - George Washington University, Washington DC, USA )
30 Oct 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation